Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPHLN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EPM2A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SGPP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | F2RL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | EYA2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SLU7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | RPS6KA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | AFAP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | NAF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CUEDC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |